Skip to main content

Year: 2025

Peyto Exploration & Development Corp. Confirms Monthly Dividend for September 15, 2025

CALGARY, Alberta, Aug. 15, 2025 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to August 2025 of $0.11 per common share is to be paid on September 15, 2025, for shareholders of record on August 31, 2025. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at www.peyto.com to learn more about what makes Peyto one of North America’s most exciting energy companies. The website also includes a monthly report, which discusses various topics chosen by the President and CEO and includes estimates of monthly capital expenditures and production. For further information please contact:Jean-Paul LachancePresident...

Continue reading

Embassy Bancorp, Inc. Announces Results of Operations as of and for the Three and Six Months Ended June 30, 2025

BETHLEHEM, Pa., Aug. 15, 2025 (GLOBE NEWSWIRE) — On August 13, 2025, Embassy Bancorp, Inc. (OTCQX: EMYB) (the “Company”) filed its Quarterly Report on Form 10-Q for the period ended June 30, 2025, a copy of which can be found at https://investors.embassybank.com/sec-filings/documents/default.aspx. Highlights of the filing, which includes consolidated financial information of the Company and Embassy Bank For the Lehigh Valley (the “Bank”), the Company’s wholly owned subsidiary, include:Cash and cash equivalents on hand of $91.8 million at June 30, 2025, or 5.2% of total assets. Deposits of $1.61 billion at June 30, 2025, an increase of $57.2 million, or 3.7%, from $1.55 billion at December 31, 2024. The Company does not have any brokered deposits. Short term borrowings of $15.6 million at December 31, 2024, were repaid in full...

Continue reading

PharmaCorp Rx Inc. Reports Q2 2025 Financial Results

SASKATOON, Saskatchewan, Aug. 15, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a growing national platform for pharmacist-led community pharmacy ownership, today reported its financial results for the three and six months ended June 30, 2025. The second quarter reflected continued operational momentum, expanding pharmacy-level contribution, and disciplined progress on the Corporation’s national acquisition strategy. Following quarter-end, PharmaCorp completed the acquisition of a fourth pharmacy in Western Canada, building further scale and reinforcing the platform’s coast-to-coast ambitions. Q2 2025 Financial HighlightsRevenues generated from three operating pharmacies, with continued growth in both prescription volumes and front-of-store sales Operating infrastructure was successfully...

Continue reading

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

    – Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial – Expanded global IP protection by securing Australian patent acceptance for the stenoparib DRP® companion diagnostic – Secured new service contract with EU biotech for Allarity Medical LaboratoryTARPON SPRINGS, Fla., August 15, 2025 — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—today reported financial results and provided an update on operational highlights for the second quarter ended June 30, 2025. “The second quarter of 2025 marked a period of strong operational execution for Allarity. Most notably, we continued to advance our lead program, stenoparib, with strong...

Continue reading

Brunswick Exploration Consolidates Mirage Ownership

MONTREAL, Aug. 15, 2025 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; FRANKFURT:1XQ; “BRW” or the “Company”) is pleased to announce the consolidation of its ownership covering a group of eight mining claims at the Mirage project pursuant to a purchase and sale agreement dated August 15, 2025, with General Partnership Osisko Baie James (“Osisko Baie James”). Brunswick Exploration now owns 100% of the mining claims across the Mirage project. To acquire such rights, Brunswick has agreed to renounce to its option to acquire a 90% undivided interest in the Plex property, pursuant to the third amendment to option agreement, dated August 15 2025, between Brunswick and Osisko Baie James. In partial consideration for the termination of the Plex Property Option pursuant to this Third Amendment Agreement, Osisko...

Continue reading

BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering

Offering Structured to Accelerate Streamex’s Operational Build-Out, Strategically Allocated with No Warrants Los Angeles, CA, Aug. 15, 2025 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), a gold tokenization infrastructure company, today announced the closing of its previously announced underwritten public offering, including a group of technology and mining thought leaders. The offering consisted of 3,852,149 shares of common stock at a public offering price of $3.90 per share with no pre-funded warrants. The gross proceeds from the offering, before deducting underwriter discounts and commissions and other estimated offering expenses were approximately $15,023,381. The Company intends to use the net proceeds from the...

Continue reading

Youxin Technology Ltd Receives Nasdaq Notifications Regarding Minimum Bid and Market Value of Listed Securities Requirements

Guangzhou, China, Aug. 15, 2025 (GLOBE NEWSWIRE) — Youxin Technology Ltd (Nasdaq: YAAS) (the “Company” or “Youxin Technology”), a software as a service (“SaaS”) and platform as a service (“PaaS”) provider committed to helping retail enterprises digitally transform their businesses, today announced that it received two staff determination notices (the “Notice(s)”) from the Listings Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on August 13, 2025. The Notices notify the Company that it is not in compliance with the minimum bid price requirement as set forth under Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq, and pursuant to Listing Rule 5550(b)(2), it is required to maintain a minimum Market Value of Listed Securities (“MVLS”) of $35 million for continued listing on the Nasdaq Capital Market...

Continue reading

Foresight Announces Plan for Reverse Share Split

Ness Ziona, Israel, Aug. 15, 2025 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, announced today that it plans to conduct a reverse share split of the Company’s outstanding ordinary shares, no par value per share, at a ratio of 1-for-7 which is expected to be implemented at market open on the Tel-Aviv Stock Exchange on August 24, 2025 and on the Nasdaq Capital Market on August 25, 2025. There will be no change to the existing ratio of the number of ordinary shares represented by the Company’s American Depositary Shares (“ADSs”). However, as a result of the reverse share split, the ADS price is expected to increase proportionally, although the Company can give no assurance that the ADS price after the reverse share split will be...

Continue reading

Smart Share Global Limited Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company from Hillhouse

SHANGHAI, Aug. 15, 2025 (GLOBE NEWSWIRE) — Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced that the board of directors received a preliminary non-binding proposal letter, dated August 13, 2025, from Hillhouse Investment Management, Ltd. (together with its affiliates, “Hillhouse”) to acquire all of the outstanding ordinary shares of the Company that are not already beneficially owned by Hillhouse or the Management Members (as defined below) for US$1.77 per ADS or US$0.885 per share in cash, subject to the acceptance by the Management Members of the similar rollover arrangement in the Merger Agreement (as defined below). On August 1, 2025, the Company announced that it had entered into a definitive Agreement and Plan of...

Continue reading

Ebang International Holdings Inc. Reports Unaudited Financial Results for the First Six Months of Fiscal Year 2025

SINGAPORE, Aug. 15, 2025 (GLOBE NEWSWIRE) — Ebang International Holdings Inc. (Nasdaq: EBON, the “Company,” “we,” “us” or “our”), today announced its unaudited financial results for the first six months of fiscal year 2025. Operational and Financial Highlights for the First Six Months of Fiscal Year 2025 Total net revenues in the first six months of 2025 were US$3.58 million, representing an 69.46% period-over-period increase from US$2.11 million in the same period of 2024. Gross loss in the first six months of 2025 was US$0.65 million compared to the gross profit of US$0.08 million in the same period of 2024. Net loss in the first six months of 2025 was US$4.50 million compared to US$6.65 million in the same period of 2024.  Mr. Dong Hu, Chairman and Chief Executive Officer of the Company, commented, “In the first half of 2025,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.